Skip to main content
ALLR
NASDAQ Life Sciences

Allarity Therapeutics Secures $6M Equity Line of Credit with Tumim Stone Capital

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.1
Mkt Cap
$17.502M
52W Low
$0.614
52W High
$2.35
52W Position info
79% above low
Off High info
53% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

ALLR sits 79% above its 52-week low of $0.614.

Summary

Allarity Therapeutics secured a flexible equity line of credit for up to $6 million, allowing the company to sell shares at a discount to market prices, with significant potential for dilution.


Key Events · Financing and Capital Events · ALLR

  • Equity Line of Credit Established

    Allarity Therapeutics entered into a Common Stock Purchase Agreement with Tumim Stone Capital LLC, providing access to up to $6,000,000 in capital.

  • Discounted Share Pricing

    Shares will be sold at a discount, specifically 95% of the lowest one-day VWAP or 97% of the lowest three-day VWAP, which is dilutive for existing shareholders.

  • Initial Exchange Cap in Effect

    Sales are initially capped at 19.99% of outstanding shares (approximately 3.25 million shares) without shareholder approval, as the current stock price is below the $1.20 'Minimum Price' threshold.

  • Shareholder Approval Sought for Cap Waiver

    The company plans to seek shareholder approval at its next annual meeting to waive the Exchange Cap, indicating a desire to raise additional capital beyond the initial limit.


Analysis · ALLR · Life Sciences

Allarity Therapeutics has entered into a Common Stock Purchase Agreement, providing the company with the option to sell up to $6,000,000 worth of newly issued common stock to Tumim Stone Capital LLC. This equity line of credit offers a flexible capital-raising mechanism, which is crucial for a company of this size in the life sciences sector. However, the shares will be sold at a discount to the volume-weighted average price (VWAP), specifically 95% or 97% of the lowest daily VWAP, which is dilutive for existing shareholders. The agreement includes an initial 'Exchange Cap' limiting sales to 19.99% of outstanding shares (approximately 3.25 million shares) without shareholder approval, as the current stock price is below the specified 'Minimum Price' of $1.20. The company's commitment to seek shareholder approval to waive this cap at its next annual meeting indicates a clear intent to potentially raise the full $6 million or more, which would result in substantial dilution.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ALLR was trading at $1.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $17.5M. The 52-week trading range was $0.61 to $2.35. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ALLR - Latest Insights

ALLR
Nov 13, 2026, 8:07 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.950
Real-time Price: $0.9348 info
Change: -$0.0152 (-2%) info
Market Cap: $15.176M info
ALLR
Nov 13, 2026, 8:05 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.950
Real-time Price: $0.9348 info
Change: -$0.0152 (-2%) info
Market Cap: $15.176M info
ALLR
Nov 02, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.8415
Real-time Price: $0.9348 info
Change: +$0.0933 (+11%) info
Market Cap: $15.176M info
ALLR
Oct 30, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.870
Real-time Price: $0.9348 info
Change: +$0.0648 (+7%) info
Market Cap: $15.176M info
ALLR
Sep 14, 2026, 12:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.21
Real-time Price: $0.9348 info
Change: -$0.2752 (-23%) info
Market Cap: $15.176M info